ONCOGENE 润色咨询

ONCOGENE

出版年份:1987 年文章数:9343 投稿命中率: 开通期刊会员,数据随心看

出版周期:Weekly 自引率:3.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1182041, encodeId=234a118204183, content=想问一下大神们 做的纯临床可以投吗 或者 那个杂志适合投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211201/d84136dee0dd4d68848cc44db50f719c/6ffa0936d1994653900ac5b4c9c895b0.jpg, createdBy=5c5f5450836, createdName=ms4000001412745107, createdTime=Sat Jan 08 00:03:29 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066596, encodeId=a7b11066596a1, content=请问这个是被拒吗<br>Stage Start Date<br>Editor in Chief Decision Complete 2nd Nov 21<br>Manuscript Decision complete 2nd Nov 21<br>Editor Decision Complete 2nd Nov 21<br>Under Consideration 1st Nov 21<br>Editor Assigned 30th Oct 21<br>Author Approved Converted Files 30th Oct 21<br>Submission 30th Oct 21, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f7c13068406, createdName=1441036817, createdTime=Wed Nov 03 14:09:11 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066561, encodeId=98d2106656148, content=oncogene最近居然有好几篇生信文章出来了,不知道是个啥信号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Nov 03 11:33:08 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074018, encodeId=2e5f10e401867, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤学<br>经验分享:接连被JCI、CCR、CR拒稿后转投Oncogene,3个月大修后居然还有补抗体芯片的小修,历经半年终于accept。感觉Oncogene口碑好是有道理的,editor和reviewer都很严谨,8-10分区间算是地狱难度了吧。 自己算的即时IF才6.77,有点慌,未来几个月冲鸭!🙏 另外求问:oncogene独立一+frontiers in immunology通讯能申下来肿瘤口的国青吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Nov 25 23:13:56 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068900, encodeId=f7e610689007c, content=审稿速度:12.0<br>偏重的研究方向:自噬;肿瘤;干细胞<br>经验分享:一审<br>Stage Start Date<br>Revision Received 1st Jul 21<br>Waiting for Revision 30th Apr 21<br>Decision Made 30th Apr 21<br>Editor in Chief Decision Complete 29th Apr 21<br>Manuscript Decision complete 29th Apr 21<br>Editor Decision Complete 29th Apr 21<br>EIC Decision Started 28th Apr 21<br>Editor Review Completed 28th Apr 21<br>All Reviewers Assigned 24th Feb 21<br>Review Started 16th Feb 21<br>First Reviewer Accepted 16th Feb 21<br>Potential Reviewers Accept 16th Feb 21<br>Contacting Reviewers 16th Feb 21<br>Reviewers Assigned 16th Feb 21<br>Waiting for Potential Reviewer Assignment 25th Jan 21<br>Monitoring Editor Assigned 25th Jan 21<br>Potential Monitoring Editor Assigned 25th Jan 21<br>Under Consideration 25th Jan 21<br>Editor Assigned 23rd Jan 21<br>Author Approved Converted Files 23rd Jan 21<br>Submission 22nd Jan 21<br>大修<br><br>二审<br>Stage Start Date<br>Revision Received 6th Sep 21<br>Waiting for Revision 6th Sep 21<br>Decision Made 6th Sep 21<br>Editor in Chief Decision Complete 4th Sep 21<br>Manuscript Decision complete 4th Sep 21<br>Editor Decision Complete 4th Sep 21<br>EIC Decision Started 3rd Sep 21<br>Editor Review Completed 3rd Sep 21<br>Receiving Editor Review Started 3rd Sep 21<br>Review Complete 3rd Sep 21<br>All Reviewers Assigned 18th Jul 21<br>Review Started 14th Jul 21<br>First Reviewer Accepted 14th Jul 21<br>Potential Reviewers Accept 14th Jul 21<br>Contacting Reviewers 14th Jul 21<br>Reviewers Assigned 14th Jul 21<br>Waiting for Potential Reviewer Assignment 5th Jul 21<br>Monitoring Editor Assigned 5th Jul 21<br>Potential Monitoring Editor Accept 5th Jul 21<br>Potential Monitoring Editor Assigned 5th Jul 21<br>Editor Assigned 1st Jul 21<br>Author Approved Converted Files 1st Jul 21<br>Submission 1st Jul 21<br>小小修,基本不需要改动,当天修回<br><br>三审<br>Stage Start Date<br>Revision Received 1st Nov 21<br>Waiting for Revision 1st Nov 21<br>Decision Made 1st Nov 21<br>Editor in Chief Decision Complete 31st Oct 21<br>Manuscript Decision complete 31st Oct 21<br>Editor Decision Complete 31st Oct 21<br>EIC Decision Started 30th Oct 21<br>Editor Review Completed 30th Oct 21<br>Receiving Editor Review Started 30th Oct 21<br>Review Complete 30th Oct 21<br>All Reviewers Assigned 19th Sep 21<br>Review Started 15th Sep 21<br>First Reviewer Accepted 15th Sep 21<br>Potential Reviewers Accept 15th Sep 21<br>Contacting Reviewers 15th Sep 21<br>Reviewers Assigned 15th Sep 21<br>Waiting for Potential Reviewer Assignment 7th Sep 21<br>Monitoring Editor Assigned 7th Sep 21<br>Potential Monitoring Editor Accept 7th Sep 21<br>Potential Monitoring Editor Assigned 7th Sep 21<br>Editor Assigned 6th Sep 21<br>Author Approved Converted Files 6th Sep 21<br>Submission 6th Sep 21<br>原则接受,等待提交终稿<br><br>四审<br>Stage Start Date<br>Decision Made 4th Nov 21<br>Editor in Chief Decision Complete 4th Nov 21<br>Manuscript Decision complete 4th Nov 21<br>Editor Decision Complete 4th Nov 21<br>Waiting for Potential Reviewer Assignment 4th Nov 21<br>Monitoring Editor Assigned 4th Nov 21<br>Potential Monitoring Editor Accept 4th Nov 21<br>Potential Monitoring Editor Assigned 4th Nov 21<br>Editor Assigned 1st Nov 21<br>Author Approved Converted Files 1st Nov 21<br>Submission 1st Nov 21<br>最终接收 <br>目前等待proof中,投稿到接收耗时9个多月,oncogene是我拿这篇论文投的第一个目标杂志,运气不错,能够直接送审并最终接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Wed Nov 10 09:41:04 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051195, encodeId=963d10511950f, content=审稿速度:1.0<br>偏重的研究方向:肿瘤学<br>经验分享:上个月中旬投稿的,一周后送审。大概20天editor回信拒了。但是奇怪的是只有一个reviewer意见,而且还是很友好的的,提出小休后发表。但是主编直接说不合适拒了。哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06982122844, createdName=wangshuai9, createdTime=Tue Sep 14 17:09:04 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903683, encodeId=b24a90368323, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:今天收到 修回:<br>Waiting for Revision 30th Nov 20<br>Decision Made 30th Nov 20<br>Editor in Chief Decision Complete 27th Nov 20<br>Manuscript Decision complete 27th Nov 20<br>Editor Decision Complete 27th Nov 20<br>EIC Decision Started 27th Nov 20<br>Editor Review Completed 27th Nov 20<br>Receiving Editor Review Started 20th Nov 20<br>Review Complete 20th Nov 20<br>All Reviewers Assigned 1st Nov 20<br>Review Started 22nd Oct 20<br>Under Consdieration 10th Oct 20<br>Contacting Reviewers 1st Oct 20<br>Reviewers Assigned 1st Oct 20<br>Waiting for Potential Reviewer Assignment 30th Sep 20<br>Monitoring Editor Assigned 30th Sep 20<br>Potential Monitoring Editor Assigned 30th Sep 20<br>Under Consideration 30th Sep 20<br>Editor Assigned 27th Sep 20<br>Author Approved Converted Files 27th Sep 20<br>Submission 27th Sep 20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab4b2396493, createdName=@@-@@, createdTime=Mon Nov 30 22:22:09 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998090, encodeId=d40c9980900f, content=偏重的研究方向: Molecular cancer ; Oncology <br>经验分享:二月中旬投稿,七月中旬最终接收,三个审稿人,两次审稿,数据量比较大,不歧视小单位令人好评,国内好点的期刊投稿被要求注明来自哪个大团队,我们这些没山头的青年博士一投稿就被拒,审都不让审,关键是期刊里边同类型的文章有的也还不如我,sad, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8452423117, createdName=qinss77, createdTime=Fri Jul 09 22:54:26 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577108, encodeId=7b535e7108f4, content=投稿页面有红色箭头吗 可以revise<span class="quote">吹不走的蒲公英 2019-09-23 发表::<br>请问,最后只有Decision Made,没有修稿是不是就是被拒了</span><span class="quote">吹不走的蒲公英 2019-09-23 00:00:00 发表:<br>请问,最后只有Decision Made,没有修稿是不是就是被拒了</span>, beContent=吹不走的蒲公英 2019-09-23 发表:: 请问,最后只有Decision Made,没有修稿是不是就是被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Sep 29 00:00:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055040, encodeId=660a1055040bb, content=请问有人知道是什么情况么?在这一步20多天了,想知道大概什么时候能进行下一步呀,看官网上说是14天左右就能给回复了,也不知道被拒的可能性大不大<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a43c5500196, createdName=ms6000000147966027, createdTime=Sun Sep 26 17:02:33 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2022-01-08 ms4000001412745107

    想问一下大神们 做的纯临床可以投吗 或者 那个杂志适合投

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1182041, encodeId=234a118204183, content=想问一下大神们 做的纯临床可以投吗 或者 那个杂志适合投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211201/d84136dee0dd4d68848cc44db50f719c/6ffa0936d1994653900ac5b4c9c895b0.jpg, createdBy=5c5f5450836, createdName=ms4000001412745107, createdTime=Sat Jan 08 00:03:29 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066596, encodeId=a7b11066596a1, content=请问这个是被拒吗<br>Stage Start Date<br>Editor in Chief Decision Complete 2nd Nov 21<br>Manuscript Decision complete 2nd Nov 21<br>Editor Decision Complete 2nd Nov 21<br>Under Consideration 1st Nov 21<br>Editor Assigned 30th Oct 21<br>Author Approved Converted Files 30th Oct 21<br>Submission 30th Oct 21, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f7c13068406, createdName=1441036817, createdTime=Wed Nov 03 14:09:11 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066561, encodeId=98d2106656148, content=oncogene最近居然有好几篇生信文章出来了,不知道是个啥信号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Nov 03 11:33:08 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074018, encodeId=2e5f10e401867, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤学<br>经验分享:接连被JCI、CCR、CR拒稿后转投Oncogene,3个月大修后居然还有补抗体芯片的小修,历经半年终于accept。感觉Oncogene口碑好是有道理的,editor和reviewer都很严谨,8-10分区间算是地狱难度了吧。 自己算的即时IF才6.77,有点慌,未来几个月冲鸭!🙏 另外求问:oncogene独立一+frontiers in immunology通讯能申下来肿瘤口的国青吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Nov 25 23:13:56 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068900, encodeId=f7e610689007c, content=审稿速度:12.0<br>偏重的研究方向:自噬;肿瘤;干细胞<br>经验分享:一审<br>Stage Start Date<br>Revision Received 1st Jul 21<br>Waiting for Revision 30th Apr 21<br>Decision Made 30th Apr 21<br>Editor in Chief Decision Complete 29th Apr 21<br>Manuscript Decision complete 29th Apr 21<br>Editor Decision Complete 29th Apr 21<br>EIC Decision Started 28th Apr 21<br>Editor Review Completed 28th Apr 21<br>All Reviewers Assigned 24th Feb 21<br>Review Started 16th Feb 21<br>First Reviewer Accepted 16th Feb 21<br>Potential Reviewers Accept 16th Feb 21<br>Contacting Reviewers 16th Feb 21<br>Reviewers Assigned 16th Feb 21<br>Waiting for Potential Reviewer Assignment 25th Jan 21<br>Monitoring Editor Assigned 25th Jan 21<br>Potential Monitoring Editor Assigned 25th Jan 21<br>Under Consideration 25th Jan 21<br>Editor Assigned 23rd Jan 21<br>Author Approved Converted Files 23rd Jan 21<br>Submission 22nd Jan 21<br>大修<br><br>二审<br>Stage Start Date<br>Revision Received 6th Sep 21<br>Waiting for Revision 6th Sep 21<br>Decision Made 6th Sep 21<br>Editor in Chief Decision Complete 4th Sep 21<br>Manuscript Decision complete 4th Sep 21<br>Editor Decision Complete 4th Sep 21<br>EIC Decision Started 3rd Sep 21<br>Editor Review Completed 3rd Sep 21<br>Receiving Editor Review Started 3rd Sep 21<br>Review Complete 3rd Sep 21<br>All Reviewers Assigned 18th Jul 21<br>Review Started 14th Jul 21<br>First Reviewer Accepted 14th Jul 21<br>Potential Reviewers Accept 14th Jul 21<br>Contacting Reviewers 14th Jul 21<br>Reviewers Assigned 14th Jul 21<br>Waiting for Potential Reviewer Assignment 5th Jul 21<br>Monitoring Editor Assigned 5th Jul 21<br>Potential Monitoring Editor Accept 5th Jul 21<br>Potential Monitoring Editor Assigned 5th Jul 21<br>Editor Assigned 1st Jul 21<br>Author Approved Converted Files 1st Jul 21<br>Submission 1st Jul 21<br>小小修,基本不需要改动,当天修回<br><br>三审<br>Stage Start Date<br>Revision Received 1st Nov 21<br>Waiting for Revision 1st Nov 21<br>Decision Made 1st Nov 21<br>Editor in Chief Decision Complete 31st Oct 21<br>Manuscript Decision complete 31st Oct 21<br>Editor Decision Complete 31st Oct 21<br>EIC Decision Started 30th Oct 21<br>Editor Review Completed 30th Oct 21<br>Receiving Editor Review Started 30th Oct 21<br>Review Complete 30th Oct 21<br>All Reviewers Assigned 19th Sep 21<br>Review Started 15th Sep 21<br>First Reviewer Accepted 15th Sep 21<br>Potential Reviewers Accept 15th Sep 21<br>Contacting Reviewers 15th Sep 21<br>Reviewers Assigned 15th Sep 21<br>Waiting for Potential Reviewer Assignment 7th Sep 21<br>Monitoring Editor Assigned 7th Sep 21<br>Potential Monitoring Editor Accept 7th Sep 21<br>Potential Monitoring Editor Assigned 7th Sep 21<br>Editor Assigned 6th Sep 21<br>Author Approved Converted Files 6th Sep 21<br>Submission 6th Sep 21<br>原则接受,等待提交终稿<br><br>四审<br>Stage Start Date<br>Decision Made 4th Nov 21<br>Editor in Chief Decision Complete 4th Nov 21<br>Manuscript Decision complete 4th Nov 21<br>Editor Decision Complete 4th Nov 21<br>Waiting for Potential Reviewer Assignment 4th Nov 21<br>Monitoring Editor Assigned 4th Nov 21<br>Potential Monitoring Editor Accept 4th Nov 21<br>Potential Monitoring Editor Assigned 4th Nov 21<br>Editor Assigned 1st Nov 21<br>Author Approved Converted Files 1st Nov 21<br>Submission 1st Nov 21<br>最终接收 <br>目前等待proof中,投稿到接收耗时9个多月,oncogene是我拿这篇论文投的第一个目标杂志,运气不错,能够直接送审并最终接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Wed Nov 10 09:41:04 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051195, encodeId=963d10511950f, content=审稿速度:1.0<br>偏重的研究方向:肿瘤学<br>经验分享:上个月中旬投稿的,一周后送审。大概20天editor回信拒了。但是奇怪的是只有一个reviewer意见,而且还是很友好的的,提出小休后发表。但是主编直接说不合适拒了。哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06982122844, createdName=wangshuai9, createdTime=Tue Sep 14 17:09:04 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903683, encodeId=b24a90368323, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:今天收到 修回:<br>Waiting for Revision 30th Nov 20<br>Decision Made 30th Nov 20<br>Editor in Chief Decision Complete 27th Nov 20<br>Manuscript Decision complete 27th Nov 20<br>Editor Decision Complete 27th Nov 20<br>EIC Decision Started 27th Nov 20<br>Editor Review Completed 27th Nov 20<br>Receiving Editor Review Started 20th Nov 20<br>Review Complete 20th Nov 20<br>All Reviewers Assigned 1st Nov 20<br>Review Started 22nd Oct 20<br>Under Consdieration 10th Oct 20<br>Contacting Reviewers 1st Oct 20<br>Reviewers Assigned 1st Oct 20<br>Waiting for Potential Reviewer Assignment 30th Sep 20<br>Monitoring Editor Assigned 30th Sep 20<br>Potential Monitoring Editor Assigned 30th Sep 20<br>Under Consideration 30th Sep 20<br>Editor Assigned 27th Sep 20<br>Author Approved Converted Files 27th Sep 20<br>Submission 27th Sep 20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab4b2396493, createdName=@@-@@, createdTime=Mon Nov 30 22:22:09 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998090, encodeId=d40c9980900f, content=偏重的研究方向: Molecular cancer ; Oncology <br>经验分享:二月中旬投稿,七月中旬最终接收,三个审稿人,两次审稿,数据量比较大,不歧视小单位令人好评,国内好点的期刊投稿被要求注明来自哪个大团队,我们这些没山头的青年博士一投稿就被拒,审都不让审,关键是期刊里边同类型的文章有的也还不如我,sad, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8452423117, createdName=qinss77, createdTime=Fri Jul 09 22:54:26 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577108, encodeId=7b535e7108f4, content=投稿页面有红色箭头吗 可以revise<span class="quote">吹不走的蒲公英 2019-09-23 发表::<br>请问,最后只有Decision Made,没有修稿是不是就是被拒了</span><span class="quote">吹不走的蒲公英 2019-09-23 00:00:00 发表:<br>请问,最后只有Decision Made,没有修稿是不是就是被拒了</span>, beContent=吹不走的蒲公英 2019-09-23 发表:: 请问,最后只有Decision Made,没有修稿是不是就是被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Sep 29 00:00:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055040, encodeId=660a1055040bb, content=请问有人知道是什么情况么?在这一步20多天了,想知道大概什么时候能进行下一步呀,看官网上说是14天左右就能给回复了,也不知道被拒的可能性大不大<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a43c5500196, createdName=ms6000000147966027, createdTime=Sun Sep 26 17:02:33 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2021-11-03 1441036817

    请问这个是被拒吗
    Stage Start Date
    Editor in Chief Decision Complete 2nd Nov 21
    Manuscript Decision complete 2nd Nov 21
    Editor Decision Complete 2nd Nov 21
    Under Consideration 1st Nov 21
    Editor Assigned 30th Oct 21
    Author Approved Converted Files 30th Oct 21
    Submission 30th Oct 21

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1182041, encodeId=234a118204183, content=想问一下大神们 做的纯临床可以投吗 或者 那个杂志适合投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211201/d84136dee0dd4d68848cc44db50f719c/6ffa0936d1994653900ac5b4c9c895b0.jpg, createdBy=5c5f5450836, createdName=ms4000001412745107, createdTime=Sat Jan 08 00:03:29 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066596, encodeId=a7b11066596a1, content=请问这个是被拒吗<br>Stage Start Date<br>Editor in Chief Decision Complete 2nd Nov 21<br>Manuscript Decision complete 2nd Nov 21<br>Editor Decision Complete 2nd Nov 21<br>Under Consideration 1st Nov 21<br>Editor Assigned 30th Oct 21<br>Author Approved Converted Files 30th Oct 21<br>Submission 30th Oct 21, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f7c13068406, createdName=1441036817, createdTime=Wed Nov 03 14:09:11 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066561, encodeId=98d2106656148, content=oncogene最近居然有好几篇生信文章出来了,不知道是个啥信号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Nov 03 11:33:08 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074018, encodeId=2e5f10e401867, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤学<br>经验分享:接连被JCI、CCR、CR拒稿后转投Oncogene,3个月大修后居然还有补抗体芯片的小修,历经半年终于accept。感觉Oncogene口碑好是有道理的,editor和reviewer都很严谨,8-10分区间算是地狱难度了吧。 自己算的即时IF才6.77,有点慌,未来几个月冲鸭!🙏 另外求问:oncogene独立一+frontiers in immunology通讯能申下来肿瘤口的国青吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Nov 25 23:13:56 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068900, encodeId=f7e610689007c, content=审稿速度:12.0<br>偏重的研究方向:自噬;肿瘤;干细胞<br>经验分享:一审<br>Stage Start Date<br>Revision Received 1st Jul 21<br>Waiting for Revision 30th Apr 21<br>Decision Made 30th Apr 21<br>Editor in Chief Decision Complete 29th Apr 21<br>Manuscript Decision complete 29th Apr 21<br>Editor Decision Complete 29th Apr 21<br>EIC Decision Started 28th Apr 21<br>Editor Review Completed 28th Apr 21<br>All Reviewers Assigned 24th Feb 21<br>Review Started 16th Feb 21<br>First Reviewer Accepted 16th Feb 21<br>Potential Reviewers Accept 16th Feb 21<br>Contacting Reviewers 16th Feb 21<br>Reviewers Assigned 16th Feb 21<br>Waiting for Potential Reviewer Assignment 25th Jan 21<br>Monitoring Editor Assigned 25th Jan 21<br>Potential Monitoring Editor Assigned 25th Jan 21<br>Under Consideration 25th Jan 21<br>Editor Assigned 23rd Jan 21<br>Author Approved Converted Files 23rd Jan 21<br>Submission 22nd Jan 21<br>大修<br><br>二审<br>Stage Start Date<br>Revision Received 6th Sep 21<br>Waiting for Revision 6th Sep 21<br>Decision Made 6th Sep 21<br>Editor in Chief Decision Complete 4th Sep 21<br>Manuscript Decision complete 4th Sep 21<br>Editor Decision Complete 4th Sep 21<br>EIC Decision Started 3rd Sep 21<br>Editor Review Completed 3rd Sep 21<br>Receiving Editor Review Started 3rd Sep 21<br>Review Complete 3rd Sep 21<br>All Reviewers Assigned 18th Jul 21<br>Review Started 14th Jul 21<br>First Reviewer Accepted 14th Jul 21<br>Potential Reviewers Accept 14th Jul 21<br>Contacting Reviewers 14th Jul 21<br>Reviewers Assigned 14th Jul 21<br>Waiting for Potential Reviewer Assignment 5th Jul 21<br>Monitoring Editor Assigned 5th Jul 21<br>Potential Monitoring Editor Accept 5th Jul 21<br>Potential Monitoring Editor Assigned 5th Jul 21<br>Editor Assigned 1st Jul 21<br>Author Approved Converted Files 1st Jul 21<br>Submission 1st Jul 21<br>小小修,基本不需要改动,当天修回<br><br>三审<br>Stage Start Date<br>Revision Received 1st Nov 21<br>Waiting for Revision 1st Nov 21<br>Decision Made 1st Nov 21<br>Editor in Chief Decision Complete 31st Oct 21<br>Manuscript Decision complete 31st Oct 21<br>Editor Decision Complete 31st Oct 21<br>EIC Decision Started 30th Oct 21<br>Editor Review Completed 30th Oct 21<br>Receiving Editor Review Started 30th Oct 21<br>Review Complete 30th Oct 21<br>All Reviewers Assigned 19th Sep 21<br>Review Started 15th Sep 21<br>First Reviewer Accepted 15th Sep 21<br>Potential Reviewers Accept 15th Sep 21<br>Contacting Reviewers 15th Sep 21<br>Reviewers Assigned 15th Sep 21<br>Waiting for Potential Reviewer Assignment 7th Sep 21<br>Monitoring Editor Assigned 7th Sep 21<br>Potential Monitoring Editor Accept 7th Sep 21<br>Potential Monitoring Editor Assigned 7th Sep 21<br>Editor Assigned 6th Sep 21<br>Author Approved Converted Files 6th Sep 21<br>Submission 6th Sep 21<br>原则接受,等待提交终稿<br><br>四审<br>Stage Start Date<br>Decision Made 4th Nov 21<br>Editor in Chief Decision Complete 4th Nov 21<br>Manuscript Decision complete 4th Nov 21<br>Editor Decision Complete 4th Nov 21<br>Waiting for Potential Reviewer Assignment 4th Nov 21<br>Monitoring Editor Assigned 4th Nov 21<br>Potential Monitoring Editor Accept 4th Nov 21<br>Potential Monitoring Editor Assigned 4th Nov 21<br>Editor Assigned 1st Nov 21<br>Author Approved Converted Files 1st Nov 21<br>Submission 1st Nov 21<br>最终接收 <br>目前等待proof中,投稿到接收耗时9个多月,oncogene是我拿这篇论文投的第一个目标杂志,运气不错,能够直接送审并最终接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Wed Nov 10 09:41:04 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051195, encodeId=963d10511950f, content=审稿速度:1.0<br>偏重的研究方向:肿瘤学<br>经验分享:上个月中旬投稿的,一周后送审。大概20天editor回信拒了。但是奇怪的是只有一个reviewer意见,而且还是很友好的的,提出小休后发表。但是主编直接说不合适拒了。哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06982122844, createdName=wangshuai9, createdTime=Tue Sep 14 17:09:04 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903683, encodeId=b24a90368323, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:今天收到 修回:<br>Waiting for Revision 30th Nov 20<br>Decision Made 30th Nov 20<br>Editor in Chief Decision Complete 27th Nov 20<br>Manuscript Decision complete 27th Nov 20<br>Editor Decision Complete 27th Nov 20<br>EIC Decision Started 27th Nov 20<br>Editor Review Completed 27th Nov 20<br>Receiving Editor Review Started 20th Nov 20<br>Review Complete 20th Nov 20<br>All Reviewers Assigned 1st Nov 20<br>Review Started 22nd Oct 20<br>Under Consdieration 10th Oct 20<br>Contacting Reviewers 1st Oct 20<br>Reviewers Assigned 1st Oct 20<br>Waiting for Potential Reviewer Assignment 30th Sep 20<br>Monitoring Editor Assigned 30th Sep 20<br>Potential Monitoring Editor Assigned 30th Sep 20<br>Under Consideration 30th Sep 20<br>Editor Assigned 27th Sep 20<br>Author Approved Converted Files 27th Sep 20<br>Submission 27th Sep 20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab4b2396493, createdName=@@-@@, createdTime=Mon Nov 30 22:22:09 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998090, encodeId=d40c9980900f, content=偏重的研究方向: Molecular cancer ; Oncology <br>经验分享:二月中旬投稿,七月中旬最终接收,三个审稿人,两次审稿,数据量比较大,不歧视小单位令人好评,国内好点的期刊投稿被要求注明来自哪个大团队,我们这些没山头的青年博士一投稿就被拒,审都不让审,关键是期刊里边同类型的文章有的也还不如我,sad, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8452423117, createdName=qinss77, createdTime=Fri Jul 09 22:54:26 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577108, encodeId=7b535e7108f4, content=投稿页面有红色箭头吗 可以revise<span class="quote">吹不走的蒲公英 2019-09-23 发表::<br>请问,最后只有Decision Made,没有修稿是不是就是被拒了</span><span class="quote">吹不走的蒲公英 2019-09-23 00:00:00 发表:<br>请问,最后只有Decision Made,没有修稿是不是就是被拒了</span>, beContent=吹不走的蒲公英 2019-09-23 发表:: 请问,最后只有Decision Made,没有修稿是不是就是被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Sep 29 00:00:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055040, encodeId=660a1055040bb, content=请问有人知道是什么情况么?在这一步20多天了,想知道大概什么时候能进行下一步呀,看官网上说是14天左右就能给回复了,也不知道被拒的可能性大不大<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a43c5500196, createdName=ms6000000147966027, createdTime=Sun Sep 26 17:02:33 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2021-11-03 H·D·E

    oncogene最近居然有好几篇生信文章出来了,不知道是个啥信号

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1182041, encodeId=234a118204183, content=想问一下大神们 做的纯临床可以投吗 或者 那个杂志适合投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211201/d84136dee0dd4d68848cc44db50f719c/6ffa0936d1994653900ac5b4c9c895b0.jpg, createdBy=5c5f5450836, createdName=ms4000001412745107, createdTime=Sat Jan 08 00:03:29 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066596, encodeId=a7b11066596a1, content=请问这个是被拒吗<br>Stage Start Date<br>Editor in Chief Decision Complete 2nd Nov 21<br>Manuscript Decision complete 2nd Nov 21<br>Editor Decision Complete 2nd Nov 21<br>Under Consideration 1st Nov 21<br>Editor Assigned 30th Oct 21<br>Author Approved Converted Files 30th Oct 21<br>Submission 30th Oct 21, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f7c13068406, createdName=1441036817, createdTime=Wed Nov 03 14:09:11 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066561, encodeId=98d2106656148, content=oncogene最近居然有好几篇生信文章出来了,不知道是个啥信号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Nov 03 11:33:08 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074018, encodeId=2e5f10e401867, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤学<br>经验分享:接连被JCI、CCR、CR拒稿后转投Oncogene,3个月大修后居然还有补抗体芯片的小修,历经半年终于accept。感觉Oncogene口碑好是有道理的,editor和reviewer都很严谨,8-10分区间算是地狱难度了吧。 自己算的即时IF才6.77,有点慌,未来几个月冲鸭!🙏 另外求问:oncogene独立一+frontiers in immunology通讯能申下来肿瘤口的国青吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Nov 25 23:13:56 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068900, encodeId=f7e610689007c, content=审稿速度:12.0<br>偏重的研究方向:自噬;肿瘤;干细胞<br>经验分享:一审<br>Stage Start Date<br>Revision Received 1st Jul 21<br>Waiting for Revision 30th Apr 21<br>Decision Made 30th Apr 21<br>Editor in Chief Decision Complete 29th Apr 21<br>Manuscript Decision complete 29th Apr 21<br>Editor Decision Complete 29th Apr 21<br>EIC Decision Started 28th Apr 21<br>Editor Review Completed 28th Apr 21<br>All Reviewers Assigned 24th Feb 21<br>Review Started 16th Feb 21<br>First Reviewer Accepted 16th Feb 21<br>Potential Reviewers Accept 16th Feb 21<br>Contacting Reviewers 16th Feb 21<br>Reviewers Assigned 16th Feb 21<br>Waiting for Potential Reviewer Assignment 25th Jan 21<br>Monitoring Editor Assigned 25th Jan 21<br>Potential Monitoring Editor Assigned 25th Jan 21<br>Under Consideration 25th Jan 21<br>Editor Assigned 23rd Jan 21<br>Author Approved Converted Files 23rd Jan 21<br>Submission 22nd Jan 21<br>大修<br><br>二审<br>Stage Start Date<br>Revision Received 6th Sep 21<br>Waiting for Revision 6th Sep 21<br>Decision Made 6th Sep 21<br>Editor in Chief Decision Complete 4th Sep 21<br>Manuscript Decision complete 4th Sep 21<br>Editor Decision Complete 4th Sep 21<br>EIC Decision Started 3rd Sep 21<br>Editor Review Completed 3rd Sep 21<br>Receiving Editor Review Started 3rd Sep 21<br>Review Complete 3rd Sep 21<br>All Reviewers Assigned 18th Jul 21<br>Review Started 14th Jul 21<br>First Reviewer Accepted 14th Jul 21<br>Potential Reviewers Accept 14th Jul 21<br>Contacting Reviewers 14th Jul 21<br>Reviewers Assigned 14th Jul 21<br>Waiting for Potential Reviewer Assignment 5th Jul 21<br>Monitoring Editor Assigned 5th Jul 21<br>Potential Monitoring Editor Accept 5th Jul 21<br>Potential Monitoring Editor Assigned 5th Jul 21<br>Editor Assigned 1st Jul 21<br>Author Approved Converted Files 1st Jul 21<br>Submission 1st Jul 21<br>小小修,基本不需要改动,当天修回<br><br>三审<br>Stage Start Date<br>Revision Received 1st Nov 21<br>Waiting for Revision 1st Nov 21<br>Decision Made 1st Nov 21<br>Editor in Chief Decision Complete 31st Oct 21<br>Manuscript Decision complete 31st Oct 21<br>Editor Decision Complete 31st Oct 21<br>EIC Decision Started 30th Oct 21<br>Editor Review Completed 30th Oct 21<br>Receiving Editor Review Started 30th Oct 21<br>Review Complete 30th Oct 21<br>All Reviewers Assigned 19th Sep 21<br>Review Started 15th Sep 21<br>First Reviewer Accepted 15th Sep 21<br>Potential Reviewers Accept 15th Sep 21<br>Contacting Reviewers 15th Sep 21<br>Reviewers Assigned 15th Sep 21<br>Waiting for Potential Reviewer Assignment 7th Sep 21<br>Monitoring Editor Assigned 7th Sep 21<br>Potential Monitoring Editor Accept 7th Sep 21<br>Potential Monitoring Editor Assigned 7th Sep 21<br>Editor Assigned 6th Sep 21<br>Author Approved Converted Files 6th Sep 21<br>Submission 6th Sep 21<br>原则接受,等待提交终稿<br><br>四审<br>Stage Start Date<br>Decision Made 4th Nov 21<br>Editor in Chief Decision Complete 4th Nov 21<br>Manuscript Decision complete 4th Nov 21<br>Editor Decision Complete 4th Nov 21<br>Waiting for Potential Reviewer Assignment 4th Nov 21<br>Monitoring Editor Assigned 4th Nov 21<br>Potential Monitoring Editor Accept 4th Nov 21<br>Potential Monitoring Editor Assigned 4th Nov 21<br>Editor Assigned 1st Nov 21<br>Author Approved Converted Files 1st Nov 21<br>Submission 1st Nov 21<br>最终接收 <br>目前等待proof中,投稿到接收耗时9个多月,oncogene是我拿这篇论文投的第一个目标杂志,运气不错,能够直接送审并最终接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Wed Nov 10 09:41:04 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051195, encodeId=963d10511950f, content=审稿速度:1.0<br>偏重的研究方向:肿瘤学<br>经验分享:上个月中旬投稿的,一周后送审。大概20天editor回信拒了。但是奇怪的是只有一个reviewer意见,而且还是很友好的的,提出小休后发表。但是主编直接说不合适拒了。哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06982122844, createdName=wangshuai9, createdTime=Tue Sep 14 17:09:04 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903683, encodeId=b24a90368323, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:今天收到 修回:<br>Waiting for Revision 30th Nov 20<br>Decision Made 30th Nov 20<br>Editor in Chief Decision Complete 27th Nov 20<br>Manuscript Decision complete 27th Nov 20<br>Editor Decision Complete 27th Nov 20<br>EIC Decision Started 27th Nov 20<br>Editor Review Completed 27th Nov 20<br>Receiving Editor Review Started 20th Nov 20<br>Review Complete 20th Nov 20<br>All Reviewers Assigned 1st Nov 20<br>Review Started 22nd Oct 20<br>Under Consdieration 10th Oct 20<br>Contacting Reviewers 1st Oct 20<br>Reviewers Assigned 1st Oct 20<br>Waiting for Potential Reviewer Assignment 30th Sep 20<br>Monitoring Editor Assigned 30th Sep 20<br>Potential Monitoring Editor Assigned 30th Sep 20<br>Under Consideration 30th Sep 20<br>Editor Assigned 27th Sep 20<br>Author Approved Converted Files 27th Sep 20<br>Submission 27th Sep 20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab4b2396493, createdName=@@-@@, createdTime=Mon Nov 30 22:22:09 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998090, encodeId=d40c9980900f, content=偏重的研究方向: Molecular cancer ; Oncology <br>经验分享:二月中旬投稿,七月中旬最终接收,三个审稿人,两次审稿,数据量比较大,不歧视小单位令人好评,国内好点的期刊投稿被要求注明来自哪个大团队,我们这些没山头的青年博士一投稿就被拒,审都不让审,关键是期刊里边同类型的文章有的也还不如我,sad, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8452423117, createdName=qinss77, createdTime=Fri Jul 09 22:54:26 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577108, encodeId=7b535e7108f4, content=投稿页面有红色箭头吗 可以revise<span class="quote">吹不走的蒲公英 2019-09-23 发表::<br>请问,最后只有Decision Made,没有修稿是不是就是被拒了</span><span class="quote">吹不走的蒲公英 2019-09-23 00:00:00 发表:<br>请问,最后只有Decision Made,没有修稿是不是就是被拒了</span>, beContent=吹不走的蒲公英 2019-09-23 发表:: 请问,最后只有Decision Made,没有修稿是不是就是被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Sep 29 00:00:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055040, encodeId=660a1055040bb, content=请问有人知道是什么情况么?在这一步20多天了,想知道大概什么时候能进行下一步呀,看官网上说是14天左右就能给回复了,也不知道被拒的可能性大不大<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a43c5500196, createdName=ms6000000147966027, createdTime=Sun Sep 26 17:02:33 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2021-11-25 dr_NEO

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向:肿瘤学
    经验分享:接连被JCI、CCR、CR拒稿后转投Oncogene,3个月大修后居然还有补抗体芯片的小修,历经半年终于accept。感觉Oncogene口碑好是有道理的,editor和reviewer都很严谨,8-10分区间算是地狱难度了吧。 自己算的即时IF才6.77,有点慌,未来几个月冲鸭!🙏 另外求问:oncogene独立一+frontiers in immunology通讯能申下来肿瘤口的国青吗?

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1182041, encodeId=234a118204183, content=想问一下大神们 做的纯临床可以投吗 或者 那个杂志适合投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211201/d84136dee0dd4d68848cc44db50f719c/6ffa0936d1994653900ac5b4c9c895b0.jpg, createdBy=5c5f5450836, createdName=ms4000001412745107, createdTime=Sat Jan 08 00:03:29 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066596, encodeId=a7b11066596a1, content=请问这个是被拒吗<br>Stage Start Date<br>Editor in Chief Decision Complete 2nd Nov 21<br>Manuscript Decision complete 2nd Nov 21<br>Editor Decision Complete 2nd Nov 21<br>Under Consideration 1st Nov 21<br>Editor Assigned 30th Oct 21<br>Author Approved Converted Files 30th Oct 21<br>Submission 30th Oct 21, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f7c13068406, createdName=1441036817, createdTime=Wed Nov 03 14:09:11 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066561, encodeId=98d2106656148, content=oncogene最近居然有好几篇生信文章出来了,不知道是个啥信号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Nov 03 11:33:08 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074018, encodeId=2e5f10e401867, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤学<br>经验分享:接连被JCI、CCR、CR拒稿后转投Oncogene,3个月大修后居然还有补抗体芯片的小修,历经半年终于accept。感觉Oncogene口碑好是有道理的,editor和reviewer都很严谨,8-10分区间算是地狱难度了吧。 自己算的即时IF才6.77,有点慌,未来几个月冲鸭!🙏 另外求问:oncogene独立一+frontiers in immunology通讯能申下来肿瘤口的国青吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Nov 25 23:13:56 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068900, encodeId=f7e610689007c, content=审稿速度:12.0<br>偏重的研究方向:自噬;肿瘤;干细胞<br>经验分享:一审<br>Stage Start Date<br>Revision Received 1st Jul 21<br>Waiting for Revision 30th Apr 21<br>Decision Made 30th Apr 21<br>Editor in Chief Decision Complete 29th Apr 21<br>Manuscript Decision complete 29th Apr 21<br>Editor Decision Complete 29th Apr 21<br>EIC Decision Started 28th Apr 21<br>Editor Review Completed 28th Apr 21<br>All Reviewers Assigned 24th Feb 21<br>Review Started 16th Feb 21<br>First Reviewer Accepted 16th Feb 21<br>Potential Reviewers Accept 16th Feb 21<br>Contacting Reviewers 16th Feb 21<br>Reviewers Assigned 16th Feb 21<br>Waiting for Potential Reviewer Assignment 25th Jan 21<br>Monitoring Editor Assigned 25th Jan 21<br>Potential Monitoring Editor Assigned 25th Jan 21<br>Under Consideration 25th Jan 21<br>Editor Assigned 23rd Jan 21<br>Author Approved Converted Files 23rd Jan 21<br>Submission 22nd Jan 21<br>大修<br><br>二审<br>Stage Start Date<br>Revision Received 6th Sep 21<br>Waiting for Revision 6th Sep 21<br>Decision Made 6th Sep 21<br>Editor in Chief Decision Complete 4th Sep 21<br>Manuscript Decision complete 4th Sep 21<br>Editor Decision Complete 4th Sep 21<br>EIC Decision Started 3rd Sep 21<br>Editor Review Completed 3rd Sep 21<br>Receiving Editor Review Started 3rd Sep 21<br>Review Complete 3rd Sep 21<br>All Reviewers Assigned 18th Jul 21<br>Review Started 14th Jul 21<br>First Reviewer Accepted 14th Jul 21<br>Potential Reviewers Accept 14th Jul 21<br>Contacting Reviewers 14th Jul 21<br>Reviewers Assigned 14th Jul 21<br>Waiting for Potential Reviewer Assignment 5th Jul 21<br>Monitoring Editor Assigned 5th Jul 21<br>Potential Monitoring Editor Accept 5th Jul 21<br>Potential Monitoring Editor Assigned 5th Jul 21<br>Editor Assigned 1st Jul 21<br>Author Approved Converted Files 1st Jul 21<br>Submission 1st Jul 21<br>小小修,基本不需要改动,当天修回<br><br>三审<br>Stage Start Date<br>Revision Received 1st Nov 21<br>Waiting for Revision 1st Nov 21<br>Decision Made 1st Nov 21<br>Editor in Chief Decision Complete 31st Oct 21<br>Manuscript Decision complete 31st Oct 21<br>Editor Decision Complete 31st Oct 21<br>EIC Decision Started 30th Oct 21<br>Editor Review Completed 30th Oct 21<br>Receiving Editor Review Started 30th Oct 21<br>Review Complete 30th Oct 21<br>All Reviewers Assigned 19th Sep 21<br>Review Started 15th Sep 21<br>First Reviewer Accepted 15th Sep 21<br>Potential Reviewers Accept 15th Sep 21<br>Contacting Reviewers 15th Sep 21<br>Reviewers Assigned 15th Sep 21<br>Waiting for Potential Reviewer Assignment 7th Sep 21<br>Monitoring Editor Assigned 7th Sep 21<br>Potential Monitoring Editor Accept 7th Sep 21<br>Potential Monitoring Editor Assigned 7th Sep 21<br>Editor Assigned 6th Sep 21<br>Author Approved Converted Files 6th Sep 21<br>Submission 6th Sep 21<br>原则接受,等待提交终稿<br><br>四审<br>Stage Start Date<br>Decision Made 4th Nov 21<br>Editor in Chief Decision Complete 4th Nov 21<br>Manuscript Decision complete 4th Nov 21<br>Editor Decision Complete 4th Nov 21<br>Waiting for Potential Reviewer Assignment 4th Nov 21<br>Monitoring Editor Assigned 4th Nov 21<br>Potential Monitoring Editor Accept 4th Nov 21<br>Potential Monitoring Editor Assigned 4th Nov 21<br>Editor Assigned 1st Nov 21<br>Author Approved Converted Files 1st Nov 21<br>Submission 1st Nov 21<br>最终接收 <br>目前等待proof中,投稿到接收耗时9个多月,oncogene是我拿这篇论文投的第一个目标杂志,运气不错,能够直接送审并最终接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Wed Nov 10 09:41:04 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051195, encodeId=963d10511950f, content=审稿速度:1.0<br>偏重的研究方向:肿瘤学<br>经验分享:上个月中旬投稿的,一周后送审。大概20天editor回信拒了。但是奇怪的是只有一个reviewer意见,而且还是很友好的的,提出小休后发表。但是主编直接说不合适拒了。哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06982122844, createdName=wangshuai9, createdTime=Tue Sep 14 17:09:04 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903683, encodeId=b24a90368323, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:今天收到 修回:<br>Waiting for Revision 30th Nov 20<br>Decision Made 30th Nov 20<br>Editor in Chief Decision Complete 27th Nov 20<br>Manuscript Decision complete 27th Nov 20<br>Editor Decision Complete 27th Nov 20<br>EIC Decision Started 27th Nov 20<br>Editor Review Completed 27th Nov 20<br>Receiving Editor Review Started 20th Nov 20<br>Review Complete 20th Nov 20<br>All Reviewers Assigned 1st Nov 20<br>Review Started 22nd Oct 20<br>Under Consdieration 10th Oct 20<br>Contacting Reviewers 1st Oct 20<br>Reviewers Assigned 1st Oct 20<br>Waiting for Potential Reviewer Assignment 30th Sep 20<br>Monitoring Editor Assigned 30th Sep 20<br>Potential Monitoring Editor Assigned 30th Sep 20<br>Under Consideration 30th Sep 20<br>Editor Assigned 27th Sep 20<br>Author Approved Converted Files 27th Sep 20<br>Submission 27th Sep 20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab4b2396493, createdName=@@-@@, createdTime=Mon Nov 30 22:22:09 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998090, encodeId=d40c9980900f, content=偏重的研究方向: Molecular cancer ; Oncology <br>经验分享:二月中旬投稿,七月中旬最终接收,三个审稿人,两次审稿,数据量比较大,不歧视小单位令人好评,国内好点的期刊投稿被要求注明来自哪个大团队,我们这些没山头的青年博士一投稿就被拒,审都不让审,关键是期刊里边同类型的文章有的也还不如我,sad, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8452423117, createdName=qinss77, createdTime=Fri Jul 09 22:54:26 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577108, encodeId=7b535e7108f4, content=投稿页面有红色箭头吗 可以revise<span class="quote">吹不走的蒲公英 2019-09-23 发表::<br>请问,最后只有Decision Made,没有修稿是不是就是被拒了</span><span class="quote">吹不走的蒲公英 2019-09-23 00:00:00 发表:<br>请问,最后只有Decision Made,没有修稿是不是就是被拒了</span>, beContent=吹不走的蒲公英 2019-09-23 发表:: 请问,最后只有Decision Made,没有修稿是不是就是被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Sep 29 00:00:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055040, encodeId=660a1055040bb, content=请问有人知道是什么情况么?在这一步20多天了,想知道大概什么时候能进行下一步呀,看官网上说是14天左右就能给回复了,也不知道被拒的可能性大不大<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a43c5500196, createdName=ms6000000147966027, createdTime=Sun Sep 26 17:02:33 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2021-11-10 洋娃娃

    审稿速度:12.0
    偏重的研究方向:自噬;肿瘤;干细胞
    经验分享:一审
    Stage Start Date
    Revision Received 1st Jul 21
    Waiting for Revision 30th Apr 21
    Decision Made 30th Apr 21
    Editor in Chief Decision Complete 29th Apr 21
    Manuscript Decision complete 29th Apr 21
    Editor Decision Complete 29th Apr 21
    EIC Decision Started 28th Apr 21
    Editor Review Completed 28th Apr 21
    All Reviewers Assigned 24th Feb 21
    Review Started 16th Feb 21
    First Reviewer Accepted 16th Feb 21
    Potential Reviewers Accept 16th Feb 21
    Contacting Reviewers 16th Feb 21
    Reviewers Assigned 16th Feb 21
    Waiting for Potential Reviewer Assignment 25th Jan 21
    Monitoring Editor Assigned 25th Jan 21
    Potential Monitoring Editor Assigned 25th Jan 21
    Under Consideration 25th Jan 21
    Editor Assigned 23rd Jan 21
    Author Approved Converted Files 23rd Jan 21
    Submission 22nd Jan 21
    大修

    二审
    Stage Start Date
    Revision Received 6th Sep 21
    Waiting for Revision 6th Sep 21
    Decision Made 6th Sep 21
    Editor in Chief Decision Complete 4th Sep 21
    Manuscript Decision complete 4th Sep 21
    Editor Decision Complete 4th Sep 21
    EIC Decision Started 3rd Sep 21
    Editor Review Completed 3rd Sep 21
    Receiving Editor Review Started 3rd Sep 21
    Review Complete 3rd Sep 21
    All Reviewers Assigned 18th Jul 21
    Review Started 14th Jul 21
    First Reviewer Accepted 14th Jul 21
    Potential Reviewers Accept 14th Jul 21
    Contacting Reviewers 14th Jul 21
    Reviewers Assigned 14th Jul 21
    Waiting for Potential Reviewer Assignment 5th Jul 21
    Monitoring Editor Assigned 5th Jul 21
    Potential Monitoring Editor Accept 5th Jul 21
    Potential Monitoring Editor Assigned 5th Jul 21
    Editor Assigned 1st Jul 21
    Author Approved Converted Files 1st Jul 21
    Submission 1st Jul 21
    小小修,基本不需要改动,当天修回

    三审
    Stage Start Date
    Revision Received 1st Nov 21
    Waiting for Revision 1st Nov 21
    Decision Made 1st Nov 21
    Editor in Chief Decision Complete 31st Oct 21
    Manuscript Decision complete 31st Oct 21
    Editor Decision Complete 31st Oct 21
    EIC Decision Started 30th Oct 21
    Editor Review Completed 30th Oct 21
    Receiving Editor Review Started 30th Oct 21
    Review Complete 30th Oct 21
    All Reviewers Assigned 19th Sep 21
    Review Started 15th Sep 21
    First Reviewer Accepted 15th Sep 21
    Potential Reviewers Accept 15th Sep 21
    Contacting Reviewers 15th Sep 21
    Reviewers Assigned 15th Sep 21
    Waiting for Potential Reviewer Assignment 7th Sep 21
    Monitoring Editor Assigned 7th Sep 21
    Potential Monitoring Editor Accept 7th Sep 21
    Potential Monitoring Editor Assigned 7th Sep 21
    Editor Assigned 6th Sep 21
    Author Approved Converted Files 6th Sep 21
    Submission 6th Sep 21
    原则接受,等待提交终稿

    四审
    Stage Start Date
    Decision Made 4th Nov 21
    Editor in Chief Decision Complete 4th Nov 21
    Manuscript Decision complete 4th Nov 21
    Editor Decision Complete 4th Nov 21
    Waiting for Potential Reviewer Assignment 4th Nov 21
    Monitoring Editor Assigned 4th Nov 21
    Potential Monitoring Editor Accept 4th Nov 21
    Potential Monitoring Editor Assigned 4th Nov 21
    Editor Assigned 1st Nov 21
    Author Approved Converted Files 1st Nov 21
    Submission 1st Nov 21
    最终接收
    目前等待proof中,投稿到接收耗时9个多月,oncogene是我拿这篇论文投的第一个目标杂志,运气不错,能够直接送审并最终接收。

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1182041, encodeId=234a118204183, content=想问一下大神们 做的纯临床可以投吗 或者 那个杂志适合投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211201/d84136dee0dd4d68848cc44db50f719c/6ffa0936d1994653900ac5b4c9c895b0.jpg, createdBy=5c5f5450836, createdName=ms4000001412745107, createdTime=Sat Jan 08 00:03:29 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066596, encodeId=a7b11066596a1, content=请问这个是被拒吗<br>Stage Start Date<br>Editor in Chief Decision Complete 2nd Nov 21<br>Manuscript Decision complete 2nd Nov 21<br>Editor Decision Complete 2nd Nov 21<br>Under Consideration 1st Nov 21<br>Editor Assigned 30th Oct 21<br>Author Approved Converted Files 30th Oct 21<br>Submission 30th Oct 21, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f7c13068406, createdName=1441036817, createdTime=Wed Nov 03 14:09:11 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066561, encodeId=98d2106656148, content=oncogene最近居然有好几篇生信文章出来了,不知道是个啥信号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Nov 03 11:33:08 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074018, encodeId=2e5f10e401867, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤学<br>经验分享:接连被JCI、CCR、CR拒稿后转投Oncogene,3个月大修后居然还有补抗体芯片的小修,历经半年终于accept。感觉Oncogene口碑好是有道理的,editor和reviewer都很严谨,8-10分区间算是地狱难度了吧。 自己算的即时IF才6.77,有点慌,未来几个月冲鸭!🙏 另外求问:oncogene独立一+frontiers in immunology通讯能申下来肿瘤口的国青吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Nov 25 23:13:56 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068900, encodeId=f7e610689007c, content=审稿速度:12.0<br>偏重的研究方向:自噬;肿瘤;干细胞<br>经验分享:一审<br>Stage Start Date<br>Revision Received 1st Jul 21<br>Waiting for Revision 30th Apr 21<br>Decision Made 30th Apr 21<br>Editor in Chief Decision Complete 29th Apr 21<br>Manuscript Decision complete 29th Apr 21<br>Editor Decision Complete 29th Apr 21<br>EIC Decision Started 28th Apr 21<br>Editor Review Completed 28th Apr 21<br>All Reviewers Assigned 24th Feb 21<br>Review Started 16th Feb 21<br>First Reviewer Accepted 16th Feb 21<br>Potential Reviewers Accept 16th Feb 21<br>Contacting Reviewers 16th Feb 21<br>Reviewers Assigned 16th Feb 21<br>Waiting for Potential Reviewer Assignment 25th Jan 21<br>Monitoring Editor Assigned 25th Jan 21<br>Potential Monitoring Editor Assigned 25th Jan 21<br>Under Consideration 25th Jan 21<br>Editor Assigned 23rd Jan 21<br>Author Approved Converted Files 23rd Jan 21<br>Submission 22nd Jan 21<br>大修<br><br>二审<br>Stage Start Date<br>Revision Received 6th Sep 21<br>Waiting for Revision 6th Sep 21<br>Decision Made 6th Sep 21<br>Editor in Chief Decision Complete 4th Sep 21<br>Manuscript Decision complete 4th Sep 21<br>Editor Decision Complete 4th Sep 21<br>EIC Decision Started 3rd Sep 21<br>Editor Review Completed 3rd Sep 21<br>Receiving Editor Review Started 3rd Sep 21<br>Review Complete 3rd Sep 21<br>All Reviewers Assigned 18th Jul 21<br>Review Started 14th Jul 21<br>First Reviewer Accepted 14th Jul 21<br>Potential Reviewers Accept 14th Jul 21<br>Contacting Reviewers 14th Jul 21<br>Reviewers Assigned 14th Jul 21<br>Waiting for Potential Reviewer Assignment 5th Jul 21<br>Monitoring Editor Assigned 5th Jul 21<br>Potential Monitoring Editor Accept 5th Jul 21<br>Potential Monitoring Editor Assigned 5th Jul 21<br>Editor Assigned 1st Jul 21<br>Author Approved Converted Files 1st Jul 21<br>Submission 1st Jul 21<br>小小修,基本不需要改动,当天修回<br><br>三审<br>Stage Start Date<br>Revision Received 1st Nov 21<br>Waiting for Revision 1st Nov 21<br>Decision Made 1st Nov 21<br>Editor in Chief Decision Complete 31st Oct 21<br>Manuscript Decision complete 31st Oct 21<br>Editor Decision Complete 31st Oct 21<br>EIC Decision Started 30th Oct 21<br>Editor Review Completed 30th Oct 21<br>Receiving Editor Review Started 30th Oct 21<br>Review Complete 30th Oct 21<br>All Reviewers Assigned 19th Sep 21<br>Review Started 15th Sep 21<br>First Reviewer Accepted 15th Sep 21<br>Potential Reviewers Accept 15th Sep 21<br>Contacting Reviewers 15th Sep 21<br>Reviewers Assigned 15th Sep 21<br>Waiting for Potential Reviewer Assignment 7th Sep 21<br>Monitoring Editor Assigned 7th Sep 21<br>Potential Monitoring Editor Accept 7th Sep 21<br>Potential Monitoring Editor Assigned 7th Sep 21<br>Editor Assigned 6th Sep 21<br>Author Approved Converted Files 6th Sep 21<br>Submission 6th Sep 21<br>原则接受,等待提交终稿<br><br>四审<br>Stage Start Date<br>Decision Made 4th Nov 21<br>Editor in Chief Decision Complete 4th Nov 21<br>Manuscript Decision complete 4th Nov 21<br>Editor Decision Complete 4th Nov 21<br>Waiting for Potential Reviewer Assignment 4th Nov 21<br>Monitoring Editor Assigned 4th Nov 21<br>Potential Monitoring Editor Accept 4th Nov 21<br>Potential Monitoring Editor Assigned 4th Nov 21<br>Editor Assigned 1st Nov 21<br>Author Approved Converted Files 1st Nov 21<br>Submission 1st Nov 21<br>最终接收 <br>目前等待proof中,投稿到接收耗时9个多月,oncogene是我拿这篇论文投的第一个目标杂志,运气不错,能够直接送审并最终接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Wed Nov 10 09:41:04 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051195, encodeId=963d10511950f, content=审稿速度:1.0<br>偏重的研究方向:肿瘤学<br>经验分享:上个月中旬投稿的,一周后送审。大概20天editor回信拒了。但是奇怪的是只有一个reviewer意见,而且还是很友好的的,提出小休后发表。但是主编直接说不合适拒了。哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06982122844, createdName=wangshuai9, createdTime=Tue Sep 14 17:09:04 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903683, encodeId=b24a90368323, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:今天收到 修回:<br>Waiting for Revision 30th Nov 20<br>Decision Made 30th Nov 20<br>Editor in Chief Decision Complete 27th Nov 20<br>Manuscript Decision complete 27th Nov 20<br>Editor Decision Complete 27th Nov 20<br>EIC Decision Started 27th Nov 20<br>Editor Review Completed 27th Nov 20<br>Receiving Editor Review Started 20th Nov 20<br>Review Complete 20th Nov 20<br>All Reviewers Assigned 1st Nov 20<br>Review Started 22nd Oct 20<br>Under Consdieration 10th Oct 20<br>Contacting Reviewers 1st Oct 20<br>Reviewers Assigned 1st Oct 20<br>Waiting for Potential Reviewer Assignment 30th Sep 20<br>Monitoring Editor Assigned 30th Sep 20<br>Potential Monitoring Editor Assigned 30th Sep 20<br>Under Consideration 30th Sep 20<br>Editor Assigned 27th Sep 20<br>Author Approved Converted Files 27th Sep 20<br>Submission 27th Sep 20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab4b2396493, createdName=@@-@@, createdTime=Mon Nov 30 22:22:09 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998090, encodeId=d40c9980900f, content=偏重的研究方向: Molecular cancer ; Oncology <br>经验分享:二月中旬投稿,七月中旬最终接收,三个审稿人,两次审稿,数据量比较大,不歧视小单位令人好评,国内好点的期刊投稿被要求注明来自哪个大团队,我们这些没山头的青年博士一投稿就被拒,审都不让审,关键是期刊里边同类型的文章有的也还不如我,sad, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8452423117, createdName=qinss77, createdTime=Fri Jul 09 22:54:26 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577108, encodeId=7b535e7108f4, content=投稿页面有红色箭头吗 可以revise<span class="quote">吹不走的蒲公英 2019-09-23 发表::<br>请问,最后只有Decision Made,没有修稿是不是就是被拒了</span><span class="quote">吹不走的蒲公英 2019-09-23 00:00:00 发表:<br>请问,最后只有Decision Made,没有修稿是不是就是被拒了</span>, beContent=吹不走的蒲公英 2019-09-23 发表:: 请问,最后只有Decision Made,没有修稿是不是就是被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Sep 29 00:00:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055040, encodeId=660a1055040bb, content=请问有人知道是什么情况么?在这一步20多天了,想知道大概什么时候能进行下一步呀,看官网上说是14天左右就能给回复了,也不知道被拒的可能性大不大<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a43c5500196, createdName=ms6000000147966027, createdTime=Sun Sep 26 17:02:33 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2021-09-14 wangshuai9

    审稿速度:1.0
    偏重的研究方向:肿瘤学
    经验分享:上个月中旬投稿的,一周后送审。大概20天editor回信拒了。但是奇怪的是只有一个reviewer意见,而且还是很友好的的,提出小休后发表。但是主编直接说不合适拒了。哎

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1182041, encodeId=234a118204183, content=想问一下大神们 做的纯临床可以投吗 或者 那个杂志适合投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211201/d84136dee0dd4d68848cc44db50f719c/6ffa0936d1994653900ac5b4c9c895b0.jpg, createdBy=5c5f5450836, createdName=ms4000001412745107, createdTime=Sat Jan 08 00:03:29 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066596, encodeId=a7b11066596a1, content=请问这个是被拒吗<br>Stage Start Date<br>Editor in Chief Decision Complete 2nd Nov 21<br>Manuscript Decision complete 2nd Nov 21<br>Editor Decision Complete 2nd Nov 21<br>Under Consideration 1st Nov 21<br>Editor Assigned 30th Oct 21<br>Author Approved Converted Files 30th Oct 21<br>Submission 30th Oct 21, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f7c13068406, createdName=1441036817, createdTime=Wed Nov 03 14:09:11 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066561, encodeId=98d2106656148, content=oncogene最近居然有好几篇生信文章出来了,不知道是个啥信号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Nov 03 11:33:08 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074018, encodeId=2e5f10e401867, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤学<br>经验分享:接连被JCI、CCR、CR拒稿后转投Oncogene,3个月大修后居然还有补抗体芯片的小修,历经半年终于accept。感觉Oncogene口碑好是有道理的,editor和reviewer都很严谨,8-10分区间算是地狱难度了吧。 自己算的即时IF才6.77,有点慌,未来几个月冲鸭!🙏 另外求问:oncogene独立一+frontiers in immunology通讯能申下来肿瘤口的国青吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Nov 25 23:13:56 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068900, encodeId=f7e610689007c, content=审稿速度:12.0<br>偏重的研究方向:自噬;肿瘤;干细胞<br>经验分享:一审<br>Stage Start Date<br>Revision Received 1st Jul 21<br>Waiting for Revision 30th Apr 21<br>Decision Made 30th Apr 21<br>Editor in Chief Decision Complete 29th Apr 21<br>Manuscript Decision complete 29th Apr 21<br>Editor Decision Complete 29th Apr 21<br>EIC Decision Started 28th Apr 21<br>Editor Review Completed 28th Apr 21<br>All Reviewers Assigned 24th Feb 21<br>Review Started 16th Feb 21<br>First Reviewer Accepted 16th Feb 21<br>Potential Reviewers Accept 16th Feb 21<br>Contacting Reviewers 16th Feb 21<br>Reviewers Assigned 16th Feb 21<br>Waiting for Potential Reviewer Assignment 25th Jan 21<br>Monitoring Editor Assigned 25th Jan 21<br>Potential Monitoring Editor Assigned 25th Jan 21<br>Under Consideration 25th Jan 21<br>Editor Assigned 23rd Jan 21<br>Author Approved Converted Files 23rd Jan 21<br>Submission 22nd Jan 21<br>大修<br><br>二审<br>Stage Start Date<br>Revision Received 6th Sep 21<br>Waiting for Revision 6th Sep 21<br>Decision Made 6th Sep 21<br>Editor in Chief Decision Complete 4th Sep 21<br>Manuscript Decision complete 4th Sep 21<br>Editor Decision Complete 4th Sep 21<br>EIC Decision Started 3rd Sep 21<br>Editor Review Completed 3rd Sep 21<br>Receiving Editor Review Started 3rd Sep 21<br>Review Complete 3rd Sep 21<br>All Reviewers Assigned 18th Jul 21<br>Review Started 14th Jul 21<br>First Reviewer Accepted 14th Jul 21<br>Potential Reviewers Accept 14th Jul 21<br>Contacting Reviewers 14th Jul 21<br>Reviewers Assigned 14th Jul 21<br>Waiting for Potential Reviewer Assignment 5th Jul 21<br>Monitoring Editor Assigned 5th Jul 21<br>Potential Monitoring Editor Accept 5th Jul 21<br>Potential Monitoring Editor Assigned 5th Jul 21<br>Editor Assigned 1st Jul 21<br>Author Approved Converted Files 1st Jul 21<br>Submission 1st Jul 21<br>小小修,基本不需要改动,当天修回<br><br>三审<br>Stage Start Date<br>Revision Received 1st Nov 21<br>Waiting for Revision 1st Nov 21<br>Decision Made 1st Nov 21<br>Editor in Chief Decision Complete 31st Oct 21<br>Manuscript Decision complete 31st Oct 21<br>Editor Decision Complete 31st Oct 21<br>EIC Decision Started 30th Oct 21<br>Editor Review Completed 30th Oct 21<br>Receiving Editor Review Started 30th Oct 21<br>Review Complete 30th Oct 21<br>All Reviewers Assigned 19th Sep 21<br>Review Started 15th Sep 21<br>First Reviewer Accepted 15th Sep 21<br>Potential Reviewers Accept 15th Sep 21<br>Contacting Reviewers 15th Sep 21<br>Reviewers Assigned 15th Sep 21<br>Waiting for Potential Reviewer Assignment 7th Sep 21<br>Monitoring Editor Assigned 7th Sep 21<br>Potential Monitoring Editor Accept 7th Sep 21<br>Potential Monitoring Editor Assigned 7th Sep 21<br>Editor Assigned 6th Sep 21<br>Author Approved Converted Files 6th Sep 21<br>Submission 6th Sep 21<br>原则接受,等待提交终稿<br><br>四审<br>Stage Start Date<br>Decision Made 4th Nov 21<br>Editor in Chief Decision Complete 4th Nov 21<br>Manuscript Decision complete 4th Nov 21<br>Editor Decision Complete 4th Nov 21<br>Waiting for Potential Reviewer Assignment 4th Nov 21<br>Monitoring Editor Assigned 4th Nov 21<br>Potential Monitoring Editor Accept 4th Nov 21<br>Potential Monitoring Editor Assigned 4th Nov 21<br>Editor Assigned 1st Nov 21<br>Author Approved Converted Files 1st Nov 21<br>Submission 1st Nov 21<br>最终接收 <br>目前等待proof中,投稿到接收耗时9个多月,oncogene是我拿这篇论文投的第一个目标杂志,运气不错,能够直接送审并最终接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Wed Nov 10 09:41:04 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051195, encodeId=963d10511950f, content=审稿速度:1.0<br>偏重的研究方向:肿瘤学<br>经验分享:上个月中旬投稿的,一周后送审。大概20天editor回信拒了。但是奇怪的是只有一个reviewer意见,而且还是很友好的的,提出小休后发表。但是主编直接说不合适拒了。哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06982122844, createdName=wangshuai9, createdTime=Tue Sep 14 17:09:04 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903683, encodeId=b24a90368323, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:今天收到 修回:<br>Waiting for Revision 30th Nov 20<br>Decision Made 30th Nov 20<br>Editor in Chief Decision Complete 27th Nov 20<br>Manuscript Decision complete 27th Nov 20<br>Editor Decision Complete 27th Nov 20<br>EIC Decision Started 27th Nov 20<br>Editor Review Completed 27th Nov 20<br>Receiving Editor Review Started 20th Nov 20<br>Review Complete 20th Nov 20<br>All Reviewers Assigned 1st Nov 20<br>Review Started 22nd Oct 20<br>Under Consdieration 10th Oct 20<br>Contacting Reviewers 1st Oct 20<br>Reviewers Assigned 1st Oct 20<br>Waiting for Potential Reviewer Assignment 30th Sep 20<br>Monitoring Editor Assigned 30th Sep 20<br>Potential Monitoring Editor Assigned 30th Sep 20<br>Under Consideration 30th Sep 20<br>Editor Assigned 27th Sep 20<br>Author Approved Converted Files 27th Sep 20<br>Submission 27th Sep 20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab4b2396493, createdName=@@-@@, createdTime=Mon Nov 30 22:22:09 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998090, encodeId=d40c9980900f, content=偏重的研究方向: Molecular cancer ; Oncology <br>经验分享:二月中旬投稿,七月中旬最终接收,三个审稿人,两次审稿,数据量比较大,不歧视小单位令人好评,国内好点的期刊投稿被要求注明来自哪个大团队,我们这些没山头的青年博士一投稿就被拒,审都不让审,关键是期刊里边同类型的文章有的也还不如我,sad, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8452423117, createdName=qinss77, createdTime=Fri Jul 09 22:54:26 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577108, encodeId=7b535e7108f4, content=投稿页面有红色箭头吗 可以revise<span class="quote">吹不走的蒲公英 2019-09-23 发表::<br>请问,最后只有Decision Made,没有修稿是不是就是被拒了</span><span class="quote">吹不走的蒲公英 2019-09-23 00:00:00 发表:<br>请问,最后只有Decision Made,没有修稿是不是就是被拒了</span>, beContent=吹不走的蒲公英 2019-09-23 发表:: 请问,最后只有Decision Made,没有修稿是不是就是被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Sep 29 00:00:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055040, encodeId=660a1055040bb, content=请问有人知道是什么情况么?在这一步20多天了,想知道大概什么时候能进行下一步呀,看官网上说是14天左右就能给回复了,也不知道被拒的可能性大不大<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a43c5500196, createdName=ms6000000147966027, createdTime=Sun Sep 26 17:02:33 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2020-11-30 @@-@@

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤
    经验分享:今天收到 修回:
    Waiting for Revision 30th Nov 20
    Decision Made 30th Nov 20
    Editor in Chief Decision Complete 27th Nov 20
    Manuscript Decision complete 27th Nov 20
    Editor Decision Complete 27th Nov 20
    EIC Decision Started 27th Nov 20
    Editor Review Completed 27th Nov 20
    Receiving Editor Review Started 20th Nov 20
    Review Complete 20th Nov 20
    All Reviewers Assigned 1st Nov 20
    Review Started 22nd Oct 20
    Under Consdieration 10th Oct 20
    Contacting Reviewers 1st Oct 20
    Reviewers Assigned 1st Oct 20
    Waiting for Potential Reviewer Assignment 30th Sep 20
    Monitoring Editor Assigned 30th Sep 20
    Potential Monitoring Editor Assigned 30th Sep 20
    Under Consideration 30th Sep 20
    Editor Assigned 27th Sep 20
    Author Approved Converted Files 27th Sep 20
    Submission 27th Sep 20

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1182041, encodeId=234a118204183, content=想问一下大神们 做的纯临床可以投吗 或者 那个杂志适合投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211201/d84136dee0dd4d68848cc44db50f719c/6ffa0936d1994653900ac5b4c9c895b0.jpg, createdBy=5c5f5450836, createdName=ms4000001412745107, createdTime=Sat Jan 08 00:03:29 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066596, encodeId=a7b11066596a1, content=请问这个是被拒吗<br>Stage Start Date<br>Editor in Chief Decision Complete 2nd Nov 21<br>Manuscript Decision complete 2nd Nov 21<br>Editor Decision Complete 2nd Nov 21<br>Under Consideration 1st Nov 21<br>Editor Assigned 30th Oct 21<br>Author Approved Converted Files 30th Oct 21<br>Submission 30th Oct 21, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f7c13068406, createdName=1441036817, createdTime=Wed Nov 03 14:09:11 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066561, encodeId=98d2106656148, content=oncogene最近居然有好几篇生信文章出来了,不知道是个啥信号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Nov 03 11:33:08 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074018, encodeId=2e5f10e401867, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤学<br>经验分享:接连被JCI、CCR、CR拒稿后转投Oncogene,3个月大修后居然还有补抗体芯片的小修,历经半年终于accept。感觉Oncogene口碑好是有道理的,editor和reviewer都很严谨,8-10分区间算是地狱难度了吧。 自己算的即时IF才6.77,有点慌,未来几个月冲鸭!🙏 另外求问:oncogene独立一+frontiers in immunology通讯能申下来肿瘤口的国青吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Nov 25 23:13:56 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068900, encodeId=f7e610689007c, content=审稿速度:12.0<br>偏重的研究方向:自噬;肿瘤;干细胞<br>经验分享:一审<br>Stage Start Date<br>Revision Received 1st Jul 21<br>Waiting for Revision 30th Apr 21<br>Decision Made 30th Apr 21<br>Editor in Chief Decision Complete 29th Apr 21<br>Manuscript Decision complete 29th Apr 21<br>Editor Decision Complete 29th Apr 21<br>EIC Decision Started 28th Apr 21<br>Editor Review Completed 28th Apr 21<br>All Reviewers Assigned 24th Feb 21<br>Review Started 16th Feb 21<br>First Reviewer Accepted 16th Feb 21<br>Potential Reviewers Accept 16th Feb 21<br>Contacting Reviewers 16th Feb 21<br>Reviewers Assigned 16th Feb 21<br>Waiting for Potential Reviewer Assignment 25th Jan 21<br>Monitoring Editor Assigned 25th Jan 21<br>Potential Monitoring Editor Assigned 25th Jan 21<br>Under Consideration 25th Jan 21<br>Editor Assigned 23rd Jan 21<br>Author Approved Converted Files 23rd Jan 21<br>Submission 22nd Jan 21<br>大修<br><br>二审<br>Stage Start Date<br>Revision Received 6th Sep 21<br>Waiting for Revision 6th Sep 21<br>Decision Made 6th Sep 21<br>Editor in Chief Decision Complete 4th Sep 21<br>Manuscript Decision complete 4th Sep 21<br>Editor Decision Complete 4th Sep 21<br>EIC Decision Started 3rd Sep 21<br>Editor Review Completed 3rd Sep 21<br>Receiving Editor Review Started 3rd Sep 21<br>Review Complete 3rd Sep 21<br>All Reviewers Assigned 18th Jul 21<br>Review Started 14th Jul 21<br>First Reviewer Accepted 14th Jul 21<br>Potential Reviewers Accept 14th Jul 21<br>Contacting Reviewers 14th Jul 21<br>Reviewers Assigned 14th Jul 21<br>Waiting for Potential Reviewer Assignment 5th Jul 21<br>Monitoring Editor Assigned 5th Jul 21<br>Potential Monitoring Editor Accept 5th Jul 21<br>Potential Monitoring Editor Assigned 5th Jul 21<br>Editor Assigned 1st Jul 21<br>Author Approved Converted Files 1st Jul 21<br>Submission 1st Jul 21<br>小小修,基本不需要改动,当天修回<br><br>三审<br>Stage Start Date<br>Revision Received 1st Nov 21<br>Waiting for Revision 1st Nov 21<br>Decision Made 1st Nov 21<br>Editor in Chief Decision Complete 31st Oct 21<br>Manuscript Decision complete 31st Oct 21<br>Editor Decision Complete 31st Oct 21<br>EIC Decision Started 30th Oct 21<br>Editor Review Completed 30th Oct 21<br>Receiving Editor Review Started 30th Oct 21<br>Review Complete 30th Oct 21<br>All Reviewers Assigned 19th Sep 21<br>Review Started 15th Sep 21<br>First Reviewer Accepted 15th Sep 21<br>Potential Reviewers Accept 15th Sep 21<br>Contacting Reviewers 15th Sep 21<br>Reviewers Assigned 15th Sep 21<br>Waiting for Potential Reviewer Assignment 7th Sep 21<br>Monitoring Editor Assigned 7th Sep 21<br>Potential Monitoring Editor Accept 7th Sep 21<br>Potential Monitoring Editor Assigned 7th Sep 21<br>Editor Assigned 6th Sep 21<br>Author Approved Converted Files 6th Sep 21<br>Submission 6th Sep 21<br>原则接受,等待提交终稿<br><br>四审<br>Stage Start Date<br>Decision Made 4th Nov 21<br>Editor in Chief Decision Complete 4th Nov 21<br>Manuscript Decision complete 4th Nov 21<br>Editor Decision Complete 4th Nov 21<br>Waiting for Potential Reviewer Assignment 4th Nov 21<br>Monitoring Editor Assigned 4th Nov 21<br>Potential Monitoring Editor Accept 4th Nov 21<br>Potential Monitoring Editor Assigned 4th Nov 21<br>Editor Assigned 1st Nov 21<br>Author Approved Converted Files 1st Nov 21<br>Submission 1st Nov 21<br>最终接收 <br>目前等待proof中,投稿到接收耗时9个多月,oncogene是我拿这篇论文投的第一个目标杂志,运气不错,能够直接送审并最终接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Wed Nov 10 09:41:04 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051195, encodeId=963d10511950f, content=审稿速度:1.0<br>偏重的研究方向:肿瘤学<br>经验分享:上个月中旬投稿的,一周后送审。大概20天editor回信拒了。但是奇怪的是只有一个reviewer意见,而且还是很友好的的,提出小休后发表。但是主编直接说不合适拒了。哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06982122844, createdName=wangshuai9, createdTime=Tue Sep 14 17:09:04 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903683, encodeId=b24a90368323, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:今天收到 修回:<br>Waiting for Revision 30th Nov 20<br>Decision Made 30th Nov 20<br>Editor in Chief Decision Complete 27th Nov 20<br>Manuscript Decision complete 27th Nov 20<br>Editor Decision Complete 27th Nov 20<br>EIC Decision Started 27th Nov 20<br>Editor Review Completed 27th Nov 20<br>Receiving Editor Review Started 20th Nov 20<br>Review Complete 20th Nov 20<br>All Reviewers Assigned 1st Nov 20<br>Review Started 22nd Oct 20<br>Under Consdieration 10th Oct 20<br>Contacting Reviewers 1st Oct 20<br>Reviewers Assigned 1st Oct 20<br>Waiting for Potential Reviewer Assignment 30th Sep 20<br>Monitoring Editor Assigned 30th Sep 20<br>Potential Monitoring Editor Assigned 30th Sep 20<br>Under Consideration 30th Sep 20<br>Editor Assigned 27th Sep 20<br>Author Approved Converted Files 27th Sep 20<br>Submission 27th Sep 20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab4b2396493, createdName=@@-@@, createdTime=Mon Nov 30 22:22:09 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998090, encodeId=d40c9980900f, content=偏重的研究方向: Molecular cancer ; Oncology <br>经验分享:二月中旬投稿,七月中旬最终接收,三个审稿人,两次审稿,数据量比较大,不歧视小单位令人好评,国内好点的期刊投稿被要求注明来自哪个大团队,我们这些没山头的青年博士一投稿就被拒,审都不让审,关键是期刊里边同类型的文章有的也还不如我,sad, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8452423117, createdName=qinss77, createdTime=Fri Jul 09 22:54:26 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577108, encodeId=7b535e7108f4, content=投稿页面有红色箭头吗 可以revise<span class="quote">吹不走的蒲公英 2019-09-23 发表::<br>请问,最后只有Decision Made,没有修稿是不是就是被拒了</span><span class="quote">吹不走的蒲公英 2019-09-23 00:00:00 发表:<br>请问,最后只有Decision Made,没有修稿是不是就是被拒了</span>, beContent=吹不走的蒲公英 2019-09-23 发表:: 请问,最后只有Decision Made,没有修稿是不是就是被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Sep 29 00:00:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055040, encodeId=660a1055040bb, content=请问有人知道是什么情况么?在这一步20多天了,想知道大概什么时候能进行下一步呀,看官网上说是14天左右就能给回复了,也不知道被拒的可能性大不大<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a43c5500196, createdName=ms6000000147966027, createdTime=Sun Sep 26 17:02:33 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2021-07-09 qinss77

    偏重的研究方向: Molecular cancer ; Oncology
    经验分享:二月中旬投稿,七月中旬最终接收,三个审稿人,两次审稿,数据量比较大,不歧视小单位令人好评,国内好点的期刊投稿被要求注明来自哪个大团队,我们这些没山头的青年博士一投稿就被拒,审都不让审,关键是期刊里边同类型的文章有的也还不如我,sad

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1182041, encodeId=234a118204183, content=想问一下大神们 做的纯临床可以投吗 或者 那个杂志适合投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211201/d84136dee0dd4d68848cc44db50f719c/6ffa0936d1994653900ac5b4c9c895b0.jpg, createdBy=5c5f5450836, createdName=ms4000001412745107, createdTime=Sat Jan 08 00:03:29 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066596, encodeId=a7b11066596a1, content=请问这个是被拒吗<br>Stage Start Date<br>Editor in Chief Decision Complete 2nd Nov 21<br>Manuscript Decision complete 2nd Nov 21<br>Editor Decision Complete 2nd Nov 21<br>Under Consideration 1st Nov 21<br>Editor Assigned 30th Oct 21<br>Author Approved Converted Files 30th Oct 21<br>Submission 30th Oct 21, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f7c13068406, createdName=1441036817, createdTime=Wed Nov 03 14:09:11 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066561, encodeId=98d2106656148, content=oncogene最近居然有好几篇生信文章出来了,不知道是个啥信号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Nov 03 11:33:08 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074018, encodeId=2e5f10e401867, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤学<br>经验分享:接连被JCI、CCR、CR拒稿后转投Oncogene,3个月大修后居然还有补抗体芯片的小修,历经半年终于accept。感觉Oncogene口碑好是有道理的,editor和reviewer都很严谨,8-10分区间算是地狱难度了吧。 自己算的即时IF才6.77,有点慌,未来几个月冲鸭!🙏 另外求问:oncogene独立一+frontiers in immunology通讯能申下来肿瘤口的国青吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Nov 25 23:13:56 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068900, encodeId=f7e610689007c, content=审稿速度:12.0<br>偏重的研究方向:自噬;肿瘤;干细胞<br>经验分享:一审<br>Stage Start Date<br>Revision Received 1st Jul 21<br>Waiting for Revision 30th Apr 21<br>Decision Made 30th Apr 21<br>Editor in Chief Decision Complete 29th Apr 21<br>Manuscript Decision complete 29th Apr 21<br>Editor Decision Complete 29th Apr 21<br>EIC Decision Started 28th Apr 21<br>Editor Review Completed 28th Apr 21<br>All Reviewers Assigned 24th Feb 21<br>Review Started 16th Feb 21<br>First Reviewer Accepted 16th Feb 21<br>Potential Reviewers Accept 16th Feb 21<br>Contacting Reviewers 16th Feb 21<br>Reviewers Assigned 16th Feb 21<br>Waiting for Potential Reviewer Assignment 25th Jan 21<br>Monitoring Editor Assigned 25th Jan 21<br>Potential Monitoring Editor Assigned 25th Jan 21<br>Under Consideration 25th Jan 21<br>Editor Assigned 23rd Jan 21<br>Author Approved Converted Files 23rd Jan 21<br>Submission 22nd Jan 21<br>大修<br><br>二审<br>Stage Start Date<br>Revision Received 6th Sep 21<br>Waiting for Revision 6th Sep 21<br>Decision Made 6th Sep 21<br>Editor in Chief Decision Complete 4th Sep 21<br>Manuscript Decision complete 4th Sep 21<br>Editor Decision Complete 4th Sep 21<br>EIC Decision Started 3rd Sep 21<br>Editor Review Completed 3rd Sep 21<br>Receiving Editor Review Started 3rd Sep 21<br>Review Complete 3rd Sep 21<br>All Reviewers Assigned 18th Jul 21<br>Review Started 14th Jul 21<br>First Reviewer Accepted 14th Jul 21<br>Potential Reviewers Accept 14th Jul 21<br>Contacting Reviewers 14th Jul 21<br>Reviewers Assigned 14th Jul 21<br>Waiting for Potential Reviewer Assignment 5th Jul 21<br>Monitoring Editor Assigned 5th Jul 21<br>Potential Monitoring Editor Accept 5th Jul 21<br>Potential Monitoring Editor Assigned 5th Jul 21<br>Editor Assigned 1st Jul 21<br>Author Approved Converted Files 1st Jul 21<br>Submission 1st Jul 21<br>小小修,基本不需要改动,当天修回<br><br>三审<br>Stage Start Date<br>Revision Received 1st Nov 21<br>Waiting for Revision 1st Nov 21<br>Decision Made 1st Nov 21<br>Editor in Chief Decision Complete 31st Oct 21<br>Manuscript Decision complete 31st Oct 21<br>Editor Decision Complete 31st Oct 21<br>EIC Decision Started 30th Oct 21<br>Editor Review Completed 30th Oct 21<br>Receiving Editor Review Started 30th Oct 21<br>Review Complete 30th Oct 21<br>All Reviewers Assigned 19th Sep 21<br>Review Started 15th Sep 21<br>First Reviewer Accepted 15th Sep 21<br>Potential Reviewers Accept 15th Sep 21<br>Contacting Reviewers 15th Sep 21<br>Reviewers Assigned 15th Sep 21<br>Waiting for Potential Reviewer Assignment 7th Sep 21<br>Monitoring Editor Assigned 7th Sep 21<br>Potential Monitoring Editor Accept 7th Sep 21<br>Potential Monitoring Editor Assigned 7th Sep 21<br>Editor Assigned 6th Sep 21<br>Author Approved Converted Files 6th Sep 21<br>Submission 6th Sep 21<br>原则接受,等待提交终稿<br><br>四审<br>Stage Start Date<br>Decision Made 4th Nov 21<br>Editor in Chief Decision Complete 4th Nov 21<br>Manuscript Decision complete 4th Nov 21<br>Editor Decision Complete 4th Nov 21<br>Waiting for Potential Reviewer Assignment 4th Nov 21<br>Monitoring Editor Assigned 4th Nov 21<br>Potential Monitoring Editor Accept 4th Nov 21<br>Potential Monitoring Editor Assigned 4th Nov 21<br>Editor Assigned 1st Nov 21<br>Author Approved Converted Files 1st Nov 21<br>Submission 1st Nov 21<br>最终接收 <br>目前等待proof中,投稿到接收耗时9个多月,oncogene是我拿这篇论文投的第一个目标杂志,运气不错,能够直接送审并最终接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Wed Nov 10 09:41:04 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051195, encodeId=963d10511950f, content=审稿速度:1.0<br>偏重的研究方向:肿瘤学<br>经验分享:上个月中旬投稿的,一周后送审。大概20天editor回信拒了。但是奇怪的是只有一个reviewer意见,而且还是很友好的的,提出小休后发表。但是主编直接说不合适拒了。哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06982122844, createdName=wangshuai9, createdTime=Tue Sep 14 17:09:04 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903683, encodeId=b24a90368323, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:今天收到 修回:<br>Waiting for Revision 30th Nov 20<br>Decision Made 30th Nov 20<br>Editor in Chief Decision Complete 27th Nov 20<br>Manuscript Decision complete 27th Nov 20<br>Editor Decision Complete 27th Nov 20<br>EIC Decision Started 27th Nov 20<br>Editor Review Completed 27th Nov 20<br>Receiving Editor Review Started 20th Nov 20<br>Review Complete 20th Nov 20<br>All Reviewers Assigned 1st Nov 20<br>Review Started 22nd Oct 20<br>Under Consdieration 10th Oct 20<br>Contacting Reviewers 1st Oct 20<br>Reviewers Assigned 1st Oct 20<br>Waiting for Potential Reviewer Assignment 30th Sep 20<br>Monitoring Editor Assigned 30th Sep 20<br>Potential Monitoring Editor Assigned 30th Sep 20<br>Under Consideration 30th Sep 20<br>Editor Assigned 27th Sep 20<br>Author Approved Converted Files 27th Sep 20<br>Submission 27th Sep 20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab4b2396493, createdName=@@-@@, createdTime=Mon Nov 30 22:22:09 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998090, encodeId=d40c9980900f, content=偏重的研究方向: Molecular cancer ; Oncology <br>经验分享:二月中旬投稿,七月中旬最终接收,三个审稿人,两次审稿,数据量比较大,不歧视小单位令人好评,国内好点的期刊投稿被要求注明来自哪个大团队,我们这些没山头的青年博士一投稿就被拒,审都不让审,关键是期刊里边同类型的文章有的也还不如我,sad, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8452423117, createdName=qinss77, createdTime=Fri Jul 09 22:54:26 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577108, encodeId=7b535e7108f4, content=投稿页面有红色箭头吗 可以revise<span class="quote">吹不走的蒲公英 2019-09-23 发表::<br>请问,最后只有Decision Made,没有修稿是不是就是被拒了</span><span class="quote">吹不走的蒲公英 2019-09-23 00:00:00 发表:<br>请问,最后只有Decision Made,没有修稿是不是就是被拒了</span>, beContent=吹不走的蒲公英 2019-09-23 发表:: 请问,最后只有Decision Made,没有修稿是不是就是被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Sep 29 00:00:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055040, encodeId=660a1055040bb, content=请问有人知道是什么情况么?在这一步20多天了,想知道大概什么时候能进行下一步呀,看官网上说是14天左右就能给回复了,也不知道被拒的可能性大不大<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a43c5500196, createdName=ms6000000147966027, createdTime=Sun Sep 26 17:02:33 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2019-09-29 bigapple001

    投稿页面有红色箭头吗 可以revise吹不走的蒲公英 2019-09-23 发表::
    请问,最后只有Decision Made,没有修稿是不是就是被拒了
    吹不走的蒲公英 2019-09-23 00:00:00 发表:
    请问,最后只有Decision Made,没有修稿是不是就是被拒了

    吹不走的蒲公英 2019-09-23 发表:: 请问,最后只有Decision Made,没有修稿是不是就是被拒了

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1182041, encodeId=234a118204183, content=想问一下大神们 做的纯临床可以投吗 或者 那个杂志适合投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211201/d84136dee0dd4d68848cc44db50f719c/6ffa0936d1994653900ac5b4c9c895b0.jpg, createdBy=5c5f5450836, createdName=ms4000001412745107, createdTime=Sat Jan 08 00:03:29 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066596, encodeId=a7b11066596a1, content=请问这个是被拒吗<br>Stage Start Date<br>Editor in Chief Decision Complete 2nd Nov 21<br>Manuscript Decision complete 2nd Nov 21<br>Editor Decision Complete 2nd Nov 21<br>Under Consideration 1st Nov 21<br>Editor Assigned 30th Oct 21<br>Author Approved Converted Files 30th Oct 21<br>Submission 30th Oct 21, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f7c13068406, createdName=1441036817, createdTime=Wed Nov 03 14:09:11 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066561, encodeId=98d2106656148, content=oncogene最近居然有好几篇生信文章出来了,不知道是个啥信号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Nov 03 11:33:08 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074018, encodeId=2e5f10e401867, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤学<br>经验分享:接连被JCI、CCR、CR拒稿后转投Oncogene,3个月大修后居然还有补抗体芯片的小修,历经半年终于accept。感觉Oncogene口碑好是有道理的,editor和reviewer都很严谨,8-10分区间算是地狱难度了吧。 自己算的即时IF才6.77,有点慌,未来几个月冲鸭!🙏 另外求问:oncogene独立一+frontiers in immunology通讯能申下来肿瘤口的国青吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Nov 25 23:13:56 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068900, encodeId=f7e610689007c, content=审稿速度:12.0<br>偏重的研究方向:自噬;肿瘤;干细胞<br>经验分享:一审<br>Stage Start Date<br>Revision Received 1st Jul 21<br>Waiting for Revision 30th Apr 21<br>Decision Made 30th Apr 21<br>Editor in Chief Decision Complete 29th Apr 21<br>Manuscript Decision complete 29th Apr 21<br>Editor Decision Complete 29th Apr 21<br>EIC Decision Started 28th Apr 21<br>Editor Review Completed 28th Apr 21<br>All Reviewers Assigned 24th Feb 21<br>Review Started 16th Feb 21<br>First Reviewer Accepted 16th Feb 21<br>Potential Reviewers Accept 16th Feb 21<br>Contacting Reviewers 16th Feb 21<br>Reviewers Assigned 16th Feb 21<br>Waiting for Potential Reviewer Assignment 25th Jan 21<br>Monitoring Editor Assigned 25th Jan 21<br>Potential Monitoring Editor Assigned 25th Jan 21<br>Under Consideration 25th Jan 21<br>Editor Assigned 23rd Jan 21<br>Author Approved Converted Files 23rd Jan 21<br>Submission 22nd Jan 21<br>大修<br><br>二审<br>Stage Start Date<br>Revision Received 6th Sep 21<br>Waiting for Revision 6th Sep 21<br>Decision Made 6th Sep 21<br>Editor in Chief Decision Complete 4th Sep 21<br>Manuscript Decision complete 4th Sep 21<br>Editor Decision Complete 4th Sep 21<br>EIC Decision Started 3rd Sep 21<br>Editor Review Completed 3rd Sep 21<br>Receiving Editor Review Started 3rd Sep 21<br>Review Complete 3rd Sep 21<br>All Reviewers Assigned 18th Jul 21<br>Review Started 14th Jul 21<br>First Reviewer Accepted 14th Jul 21<br>Potential Reviewers Accept 14th Jul 21<br>Contacting Reviewers 14th Jul 21<br>Reviewers Assigned 14th Jul 21<br>Waiting for Potential Reviewer Assignment 5th Jul 21<br>Monitoring Editor Assigned 5th Jul 21<br>Potential Monitoring Editor Accept 5th Jul 21<br>Potential Monitoring Editor Assigned 5th Jul 21<br>Editor Assigned 1st Jul 21<br>Author Approved Converted Files 1st Jul 21<br>Submission 1st Jul 21<br>小小修,基本不需要改动,当天修回<br><br>三审<br>Stage Start Date<br>Revision Received 1st Nov 21<br>Waiting for Revision 1st Nov 21<br>Decision Made 1st Nov 21<br>Editor in Chief Decision Complete 31st Oct 21<br>Manuscript Decision complete 31st Oct 21<br>Editor Decision Complete 31st Oct 21<br>EIC Decision Started 30th Oct 21<br>Editor Review Completed 30th Oct 21<br>Receiving Editor Review Started 30th Oct 21<br>Review Complete 30th Oct 21<br>All Reviewers Assigned 19th Sep 21<br>Review Started 15th Sep 21<br>First Reviewer Accepted 15th Sep 21<br>Potential Reviewers Accept 15th Sep 21<br>Contacting Reviewers 15th Sep 21<br>Reviewers Assigned 15th Sep 21<br>Waiting for Potential Reviewer Assignment 7th Sep 21<br>Monitoring Editor Assigned 7th Sep 21<br>Potential Monitoring Editor Accept 7th Sep 21<br>Potential Monitoring Editor Assigned 7th Sep 21<br>Editor Assigned 6th Sep 21<br>Author Approved Converted Files 6th Sep 21<br>Submission 6th Sep 21<br>原则接受,等待提交终稿<br><br>四审<br>Stage Start Date<br>Decision Made 4th Nov 21<br>Editor in Chief Decision Complete 4th Nov 21<br>Manuscript Decision complete 4th Nov 21<br>Editor Decision Complete 4th Nov 21<br>Waiting for Potential Reviewer Assignment 4th Nov 21<br>Monitoring Editor Assigned 4th Nov 21<br>Potential Monitoring Editor Accept 4th Nov 21<br>Potential Monitoring Editor Assigned 4th Nov 21<br>Editor Assigned 1st Nov 21<br>Author Approved Converted Files 1st Nov 21<br>Submission 1st Nov 21<br>最终接收 <br>目前等待proof中,投稿到接收耗时9个多月,oncogene是我拿这篇论文投的第一个目标杂志,运气不错,能够直接送审并最终接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Wed Nov 10 09:41:04 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051195, encodeId=963d10511950f, content=审稿速度:1.0<br>偏重的研究方向:肿瘤学<br>经验分享:上个月中旬投稿的,一周后送审。大概20天editor回信拒了。但是奇怪的是只有一个reviewer意见,而且还是很友好的的,提出小休后发表。但是主编直接说不合适拒了。哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06982122844, createdName=wangshuai9, createdTime=Tue Sep 14 17:09:04 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903683, encodeId=b24a90368323, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:今天收到 修回:<br>Waiting for Revision 30th Nov 20<br>Decision Made 30th Nov 20<br>Editor in Chief Decision Complete 27th Nov 20<br>Manuscript Decision complete 27th Nov 20<br>Editor Decision Complete 27th Nov 20<br>EIC Decision Started 27th Nov 20<br>Editor Review Completed 27th Nov 20<br>Receiving Editor Review Started 20th Nov 20<br>Review Complete 20th Nov 20<br>All Reviewers Assigned 1st Nov 20<br>Review Started 22nd Oct 20<br>Under Consdieration 10th Oct 20<br>Contacting Reviewers 1st Oct 20<br>Reviewers Assigned 1st Oct 20<br>Waiting for Potential Reviewer Assignment 30th Sep 20<br>Monitoring Editor Assigned 30th Sep 20<br>Potential Monitoring Editor Assigned 30th Sep 20<br>Under Consideration 30th Sep 20<br>Editor Assigned 27th Sep 20<br>Author Approved Converted Files 27th Sep 20<br>Submission 27th Sep 20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab4b2396493, createdName=@@-@@, createdTime=Mon Nov 30 22:22:09 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998090, encodeId=d40c9980900f, content=偏重的研究方向: Molecular cancer ; Oncology <br>经验分享:二月中旬投稿,七月中旬最终接收,三个审稿人,两次审稿,数据量比较大,不歧视小单位令人好评,国内好点的期刊投稿被要求注明来自哪个大团队,我们这些没山头的青年博士一投稿就被拒,审都不让审,关键是期刊里边同类型的文章有的也还不如我,sad, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8452423117, createdName=qinss77, createdTime=Fri Jul 09 22:54:26 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577108, encodeId=7b535e7108f4, content=投稿页面有红色箭头吗 可以revise<span class="quote">吹不走的蒲公英 2019-09-23 发表::<br>请问,最后只有Decision Made,没有修稿是不是就是被拒了</span><span class="quote">吹不走的蒲公英 2019-09-23 00:00:00 发表:<br>请问,最后只有Decision Made,没有修稿是不是就是被拒了</span>, beContent=吹不走的蒲公英 2019-09-23 发表:: 请问,最后只有Decision Made,没有修稿是不是就是被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Sep 29 00:00:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055040, encodeId=660a1055040bb, content=请问有人知道是什么情况么?在这一步20多天了,想知道大概什么时候能进行下一步呀,看官网上说是14天左右就能给回复了,也不知道被拒的可能性大不大<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a43c5500196, createdName=ms6000000147966027, createdTime=Sun Sep 26 17:02:33 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2021-09-26 ms6000000147966027

    请问有人知道是什么情况么?在这一步20多天了,想知道大概什么时候能进行下一步呀,看官网上说是14天左右就能给回复了,也不知道被拒的可能性大不大

    1

    展开1条回复
共500条页码: 5/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分